Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Screen for 21-hydroxylase deficiency, the most common congenital adrenal insufficiency.
New York DOH Approval Status
Indicates whether a test has been approved by the New York State Department of Health.
This test is New York state approved.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
Collect between 6-10 a.m.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Serum separator tube or green (sodium or lithium heparin). Also acceptable: Pink (K2EDTA).
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1.8 mL serum or plasma to an ARUP Standard Transport Tube and freeze immediately. (Min: 0.9 mL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
CRITICAL FROZEN.Separate specimens must be submitted when multiple tests are ordered.
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Refrigerated or room temperature specimens.
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
After separation from cells: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 6 months
Methodology
Process(es) used to perform the test.
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Performed
Days of the week the test is performed.
Sun-Sat
Reported
Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-5 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Test Number
Components
Reference Interval
17-Hydroxyprogesterone, HPLC-MS/MS
Age
Male (ng/dL)
Female (ng/dL)
Premature (26-28 weeks)
124-841
124-841
Premature (29-35 weeks)
26-568
26-568
Full term Day 3
7-77
7-77
4 days-30 days
Less than 200
7-106
1 month-2 months
Less than 200
13-106
3 months-5 months
3-90
13-106
6 months-1 year
Less than or equal to 148
Less than or equal to 148
2-3 years
Less than or equal to 228
Less than or equal to 256
4-6 years
Less than or equal to 208
Less than or equal to 299
7-9 years
Less than or equal to 63
Less than or equal to 71
10-12 years
Less than or equal to 79
Less than or equal to 129
13-15 years
9-140
9-208
16-17 years
24-192
Less than or equal to 178
18 years and older
Less than 139
Less than 207
Follicular
Not Applicable
15-70
Luteal
Not Applicable
35-290
Tanner Stage I
Less than or equal to 62
Less than or equal to 74
Tanner Stage II
Less than or equal to 104
Less than or equal to 164
Tanner Stage III
Less than or equal to 151
13-209
Tanner Stage IV-V
20-173
7-170
17-Hydroxypregnenolone Quant, MS/MS, Ser
Age
Male (ng/dL)
Female (ng/dL)
Premature (26-28 weeks)
1219-9799
1219-9799
Premature (29-36 weeks)
346-8911
346-8911
Full Term (1-5 months)
229-3104
229-3104
6-12 months
Less than or equal to 917
Less than or equal to 917
13-23 months
Less than or equal to 592
Less than or equal to 592
2-4 years
Less than or equal to 249
Less than or equal to 280
5-6 years
Less than or equal to 319
Less than or equal to 350
7-9 years
Less than or equal to 187
Less than or equal to 212
10-12 years
Less than or equal to 392
Less than or equal to 398
13-15 years
35-465
Less than or equal to 407
16-17 years
32-478
Less than or equal to 423
18 years and older
Less than 442
Less than 226
Tanner Stage I
Less than or equal to 208
Less than or equal to 235
Tanner Stage II
Less than or equal to 355
Less than or equal to 367
Tanner Stage III
Less than or equal to 450
Less than or equal to 430
Tanner Stage IV & V
35-478
Less than or equal to 412
Androstenedione by TMS
Age
Male (ng/mL)
Female (ng/mL)
Premature Infants (26-28 weeks Day 4)
0.92-2.82
0.92-2.82
Premature Infants (31-35 weeks Day 4)
0.80-4.46
0.80-4.46
Full Term Infants (1-7 days)
0.20-2.90
0.20-2.90
8-30 days
0.18-0.80
0.18-0.80
1-5 months
0.06-0.68
0.06-0.68
6-24 months
0.03-0.15
Less than 0.15
2-3 years
Less than 0.11
Less than 0.16
4-5 years
0.02-0.17
0.02-0.21
6-7 years
0.01-0.29
0.02-0.28
8-9 years
0.03-0.30
0.04-0.42
10-11 years
0.07-0.39
0.09-1.23
12-13 years
0.10-0.64
0.24-1.73
14-15 years
0.18-0.94
0.39-2.00
16-17 years
0.30-1.13
0.35-2.12
18-39 years
0.33-1.34
0.26-2.14
40 years and older
0.23-0.89
0.13-0.82
Premenopausal
Not Applicable
0.26-2.14
Postmenopausal
Not Applicable
0.13-0.82
Tanner Stage I
0.04-0.32
0.05-0.51
Tanner Stage II
0.08-0.48
0.15-1.37
Tanner Stage III
0.14-0.87
0.37-2.24
Tanner Stage IV-V
0.27-1.07
0.35-2.05
Dehydroepiandrosterone by TMS
Age
Male (ng/mL)
Female (ng/mL)
Premature
Less than 40
Less than 40
0-1 days
Less than 11
Less than 11
2-6 days
Less than 8.7
Less than 8.7
7 days-1 month
Less than 5.8
Less than 5.8
1-5 months
Less than 2.9
Less than 2.9
6-24 months
Less than 2.5
Less than 1.99
2-3 years
Less than 0.63
Less than 0.85
4-5 years
Less than 0.95
Less than 1.03
6-7 years
0.06-1.93
Less than 1.79
8-9 years
0.10-2.08
0.14-2.35
10-11 years
0.32-3.08
0.43-3.78
12-13 years
0.57-4.10
0.89-6.21
14-15 years
0.93-6.04
1.22-7.01
16-17 years
1.17-6.52
1.42-9.00
18-39 years
1.33-7.78
1.33-7.78
40 years and older
0.63-4.70
0.63-4.70
Postmenopausal
Not Applicable
0.60-5.73
Tanner Stage I
0.11-2.37
0.14-2.76
Tanner Stage II
0.37-3.66
0.83-4.87
Tanner Stage III
0.75-5.24
1.08-7.56
Tanner Stage IV-V
1.22-6.73
1.24-7.88
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Connect Sign In
